Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (formerly Jaguar Animal Health, Inc.) on August 29, 2017. The filing serves to provide unaudited financial statements of Napo Pharmaceuticals, Inc. ("Napo") and unaudited pro forma financial statements for the combined entity following the completion of their merger on July 31, 2017.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references the inclusion of unaudited financial statements for Napo as of June 30, 2017, and for the six months ended June 30, 2017 and 2016, as well as pro forma statements for the combined company for the six months ended June 30, 2017. These detailed metrics are contained in Exhibits 99.1 and 99.2 attached to the filing.
Material Changes
The primary material change reported is the completion of the Merger with Napo Pharmaceuticals, Inc. on July 31, 2017, pursuant to an Agreement and Plan of Merger dated March 31, 2017. This transaction resulted in the acquisition of Napo's business and the subsequent filing of updated financial statements to reflect the combined entity's financial position.
Outlook, Risks, and Unusual Items
Management intends to file registration statements on Form S-3 with the Securities and Exchange Commission. The Updated Financial Statements included in this filing are intended for incorporation by reference into those Registration Statements. The filing does not explicitly detail new risks, contingencies, or unusual items beyond the structural changes resulting from the merger.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited financial statements of Napo Pharmaceuticals, Inc. to assess the acquired entity's financial health.
- Examine Exhibit 99.2 for the unaudited pro forma financial statements to understand the combined company's projected financial position as of June 30, 2017.
- Monitor upcoming Form S-3 registration statements for details on future capital raising activities.
- Verify the integration progress of Napo's operations into Jaguar Health following the July 31, 2017 merger completion.